Market Performance
Halozyme Therapeutics, Inc. (NASDAQ:HALO) surged 5.4% in today's trading, closing at $115.53.
The Healthcare stock traded 459,962 shares, below its average daily volume of 2,520,371.5 shares.
big mover upNASDAQ:HALO
Halozyme Therapeutics, Inc. (HALO) Surges 5.4% on Heavy Volume
Halozyme Therapeutics, Inc. (NASDAQ:HALO) surged 5.4% in today's trading, closing at $115.53.
At publication ·
What changed
Halozyme Therapeutics, Inc. (NASDAQ:HALO) · big mover up
- Price at event
- $115.53
- Price change
- 5.39%
- Average volume to event volume
- 2.5M to 460K
- 52-week high
- $116.85
- 52-week low
- $61.23
At a glance
Key takeaways
- Halozyme stock surged 5.4% to close at $115.53, but trading volume of 459,962 shares was below its daily average of 2.5 million shares.
Company Overview
Halozyme Therapeutics, Inc. has a market capitalization of $7.3B. The stock has traded year-to-date.
Sharp single-day moves like this rally in Halozyme Therapeutics, Inc. are often driven by news catalysts — earnings surprises, analyst actions, sector developments, or broader market conditions. Investors should identify the specific driver before making trading decisions, as the sustainability of the move depends on whether the catalyst changes the fundamental outlook.
Halozyme Therapeutics, Inc. currently trades at $115.53, positioning the stock at the 98th percentile of its 52-week range ($61.23 — $116.84). This range context helps investors assess whether the stock is trading near support, resistance, or fair value relative to its recent history.
Related Tools: View HALO Stock Page
Frequently Asked Questions
What is causing HALO's price movement?
Price movements can be driven by earnings, analyst actions, or sector trends. Check the latest on our HALO news page.
What is HALO's 52-week range?
See full price history and interactive charts on our HALO chart page.